US Patent Issued to Zylorion Health on April 22 for "Uses of a co-crystal of psilocybin and psilocin" (Canadian Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,068, issued on April 22, was assigned to Zylorion Health Inc. (Calgary, Canada).

"Uses of a co-crystal of psilocybin and psilocin" was invented by Peter Silverstone (Calgary, Canada), Robert Laprairie (Saskatoon, Canada) and Deborah Kurrasch (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a method of treating or ameliorating a disease or disorder in a subject in need thereof, comprising administering to the subject a composition comprising a crystalline form of psilocin and psilocybin, wherein the crystalline form is co-crystal form A of psilocin and psilocybin. The disclosure further provides methods o...